You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ZVRA Exercise Disclosure
Mcfarlane Neil F. · SEC Form 4 · Filed Oct 13, 2026
Exercise
Reported value range
Not reported
Mcfarlane Neil F. President And CEO
ZVRA
Zevra Therapeutics
ZVRA
Transaction date
Oct 10, 2026
Public filing date
Oct 13, 2026
Filing lag
Filed 3 days later
ZVRA daily price context
Close on/before transaction
$11.39
Oct 9, 2026
First close after public filing
$10.23
Oct 14, 2026
Return after filing · so far
+16.28%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 50,000 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001434647-26-000075
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$224.95K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Zevra Therapeutics, Inc. ZVRA | Sale | Oct 12, 2026 | $224.95K |
| Zevra Therapeutics, Inc. ZVRA Current | Exercise | Oct 10, 2026 | Not reported |
| Zevra Therapeutics, Inc. ZVRA | Exercise | Oct 10, 2026 | $0 |